Diagnostic Value of D-dimer/Fibrinogen Ratio in Patients With Acute Aortic Dissection

NCT ID: NCT04251247

Last Updated: 2024-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

159 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-01

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute aortic dissection is rare but potentially life-threatening disease with an incidence of 5-30 cases per million, annually. Therefore prompt diagnosis is crucial. D-dimer values have been shown to be useful in the diagnosis of acute aortic dissection. Fibrinogen levels have been shown to be low, normal or high in individuals with acute aortic dissection. This study aims to investigate whether D-dimer/fibrinogen ratio can be valuable for diagnosis of acute aortic dissection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Dissection Pulmonary Embolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acute aortic dissection

Patients with a diagnosis of acute aortic dissection.

D-dimer/fibrinogen ratio

Intervention Type DIAGNOSTIC_TEST

The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)

Acute pulmonary embolism

Patients with a diagnosis of acute pulmonary embolism

D-dimer/fibrinogen ratio

Intervention Type DIAGNOSTIC_TEST

The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)

Non-cardiac chest pain

Patients with non-cardiac chest pain

D-dimer/fibrinogen ratio

Intervention Type DIAGNOSTIC_TEST

The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

D-dimer/fibrinogen ratio

The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of acute aortic dissection
* Diagnosis of acute pulmonary embolism
* Diagnosis of non-cardiac chest pain

Exclusion Criteria

* Any etiology of chest pain other than acute aortic dissection, acute pulmonary embolism, or non-cardiac chest pain
* Participants who do not give consent for enrollment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr. Lutfi Kirdar Kartal Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmet Can Topcu

Director of Department of Cardiovascular Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Kartal Dr. Lutfi Kirdar Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Avni Uygar Seyhan, M.D.

Role: CONTACT

902164583000 ext. 30202

Ahmet Can Topcu, M.D.

Role: CONTACT

902164583000 ext. 22105

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmet Bolukcu, M.D.

Role: primary

902165424444 ext. 4524

Avni Uygar Seyhan, M.D.

Role: primary

902164583000 ext. 30202

Ahmet Can Topcu, M.D.

Role: backup

902164583000 ext. 22105

References

Explore related publications, articles, or registry entries linked to this study.

Hajsadeghi S, Kerman SR, Khojandi M, Vaferi H, Ramezani R, Jourshari NM, Mousavi SA, Pouraliakbar H. Accuracy of D-dimer:fibrinogen ratio to diagnose pulmonary thromboembolism in patients admitted to intensive care units. Cardiovasc J Afr. 2012 Sep;23(8):446-56. doi: 10.5830/CVJA-2012-041.

Reference Type BACKGROUND
PMID: 23044500 (View on PubMed)

Kara H, Bayir A, Degirmenci S, Kayis SA, Akinci M, Ak A, Celik B, Dogru A, Ozturk B. D-dimer and D-dimer/fibrinogen ratio in predicting pulmonary embolism in patients evaluated in a hospital emergency department. Acta Clin Belg. 2014 Aug;69(4):240-5. doi: 10.1179/2295333714Y.0000000029.

Reference Type BACKGROUND
PMID: 25012747 (View on PubMed)

Guan XL, Wang XL, Liu YY, Lan F, Gong M, Li HY, Liu O, Jiang WJ, Liu YM, Zhu JM, Sun LZ, Zhang HJ. Changes in the Hemostatic System of Patients With Acute Aortic Dissection Undergoing Aortic Arch Surgery. Ann Thorac Surg. 2016 Mar;101(3):945-51. doi: 10.1016/j.athoracsur.2015.08.047. Epub 2015 Oct 23.

Reference Type BACKGROUND
PMID: 26603023 (View on PubMed)

Eggebrecht H, Naber CK, Bruch C, Kroger K, von Birgelen C, Schmermund A, Wichert M, Bartel T, Mann K, Erbel R. Value of plasma fibrin D-dimers for detection of acute aortic dissection. J Am Coll Cardiol. 2004 Aug 18;44(4):804-9. doi: 10.1016/j.jacc.2004.04.053.

Reference Type BACKGROUND
PMID: 15312863 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020/514/169/B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transthyretin Cardiac Amyloidosis in HFpEF
NCT03414632 COMPLETED EARLY_PHASE1